Gary Scott Leiserowitz

Title(s)Professor, Obstetrics and Gynecology
SchoolSchool of Medicine
Address4860 Y Street, Suite 2500
CA 95817
Phone916-734-6938
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Perspectives of gynecologic oncology fellowship training and preparedness for practice. Gynecol Oncol Rep. 2024 Feb; 51:101319. Nguyen NT, Jang AM, Pomerantz T, Zavorsky GS, Leiserowitz G, Brooks RA. PMID: 38223656; PMCID: PMC10787252.
      View in: PubMed   Mentions: 1  
    2. Characterizing the regulatory Fas (CD95) epitope critical for agonist antibody targeting and CAR-T bystander function in ovarian cancer. Cell Death Differ. 2023 Nov; 30(11):2408-2431. Mondal T, Gaur H, Wamba BEN, Michalak AG, Stout C, Watson MR, Aleixo SL, Singh A, Condello S, Faller R, Leiserowitz GS, Bhatnagar S, Tushir-Singh J. PMID: 37838774; PMCID: PMC10657439.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    3. Targeting RAS-ERK pathway alterations with MEK inhibitors to improve chemosensitivity in high grade serous ovarian cancers. Gynecol Oncol. 2023 Nov; 178:69-79. Nguyen NT, Raetz A, Montoya D, Schilling V, Tong C, Brooks RA, Leiserowitz G, Chien J. PMID: 37806229.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    4. Documentation of Infertility Risk Discussion in Cancer Patients Receiving Cancer-Directed Therapy: The UC Davis Cancer Center Experience. J Adolesc Young Adult Oncol. 2023 Aug 22. McCann C, Kamiyama N, Burgess D, Usher AE, Fine J, Wilson M, Iannucci A, Leiserowitz GS, Malogolowkin M. PMID: 37610879.
      View in: PubMed   Mentions: 1     Fields:    
    5. Time to completion of radiation treatment in locally advanced squamous cell carcinoma of the vulva and the impact on survival. Gynecol Oncol. 2022 11; 167(2):159-166. Nguyen NT, Zhao X, Ponzini M, Wilson M, Leiserowitz G, Brooks RA. PMID: 36154760; PMCID: PMC10030377.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022. J Natl Compr Canc Netw. 2022 09; 20(9):972-980. Armstrong DK, Alvarez RD, Backes FJ, Bakkum-Gamez JN, Barroilhet L, Behbakht K, Berchuck A, Chen LM, Chitiyo VC, Cristea M, DeRosa M, Eisenhauer EL, Gershenson DM, Gray HJ, Grisham R, Hakam A, Jain A, Karam A, Konecny GE, Leath Iii CA, Leiserowitz G, Liu J, Martin L, Matei D, McHale M, McLean K, Miller DS, Percac-Lima S, Remmenga SW, Schorge J, Stewart D, Thaker PH, Vargas R, Hendrickson AW, Werner TL, Zsiros E, Dwyer MA, Hang L. PMID: 36075393.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    7. Multiple Components of Protein Homeostasis Pathway Can Be Targeted to Produce Drug Synergies with VCP Inhibitors in Ovarian Cancer. Cancers (Basel). 2022 Jun 15; 14(12). Bastola P, Leiserowitz GS, Chien J. PMID: 35740614; PMCID: PMC9220887.
      View in: PubMed   Mentions: 2  
    8. Tetraspanins are unevenly distributed across single extracellular vesicles and bias sensitivity to multiplexed cancer biomarkers. J Nanobiotechnology. 2021 Aug 21; 19(1):250. Mizenko RR, Brostoff T, Rojalin T, Koster HJ, Swindell HS, Leiserowitz GS, Wang A, Carney RP. PMID: 34419056; PMCID: PMC8379740.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    9. Short-term organoid culture for drug sensitivity testing of high-grade serous carcinoma. Gynecol Oncol. 2020 06; 157(3):783-792. Chen H, Gotimer K, De Souza C, Tepper CG, Karnezis AN, Leiserowitz GS, Chien J, Smith LH. PMID: 32253045; PMCID: PMC7819712.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    10. Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial. Lancet Oncol. 2019 06; 20(6):862-876. Vergote I, Scambia G, O'Malley DM, Van Calster B, Park SY, Del Campo JM, Meier W, Bamias A, Colombo N, Wenham RM, Covens A, Marth C, Raza Mirza M, Kroep JR, Ma H, Pickett CA, Monk BJ, TRINOVA-3/ENGOT-ov2/GOG-3001 investigators. PMID: 31076365.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCTClinical Trials
    11. Multiple Reaction Monitoring for the Quantitation of Serum Protein Glycosylation Profiles: Application to Ovarian Cancer. J Proteome Res. 2018 01 05; 17(1):222-233. Miyamoto S, Stroble CD, Taylor S, Hong Q, Lebrilla CB, Leiserowitz GS, Kim K, Ruhaak LR. PMID: 29207246; PMCID: PMC6203861.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    12. The Use of Endometrial Cancer Patient-Derived Organoid Culture for Drug Sensitivity Testing Is Feasible. Int J Gynecol Cancer. 2017 10; 27(8):1701-1707. Girda E, Huang EC, Leiserowitz GS, Smith LH. PMID: 28683005; PMCID: PMC5627540.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    13. Optimal perioperative anesthesia management for gynecologic interstitial brachytherapy. J Contemp Brachytherapy. 2017 Jun; 9(3):216-223. Nielsen AA, Liyanage TA, Leiserowitz GS, Mayadev J. PMID: 28725244; PMCID: PMC5509989.
      View in: PubMed   Mentions: 4  
    14. Factors Predicting Use of Neoadjuvant Chemotherapy Compared With Primary Debulking Surgery in Advanced Stage Ovarian Cancer-A National Cancer Database Study. Int J Gynecol Cancer. 2017 05; 27(4):675-683. Leiserowitz GS, Lin JF, Tergas AI, Cliby WA, Bristow RE. PMID: 28328580; PMCID: PMC5405779.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    15. Multispectral Optical Tweezers for Biochemical Fingerprinting of CD9-Positive Exosome Subpopulations. Anal Chem. 2017 05 16; 89(10):5357-5363. Carney RP, Hazari S, Colquhoun M, Tran D, Hwang B, Mulligan MS, Bryers JD, Girda E, Leiserowitz GS, Smith ZJ, Lam KS. PMID: 28345878; PMCID: PMC5551404.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimalsCells
    16. Glycoproteomic Analysis of Malignant Ovarian Cancer Ascites Fluid Identifies Unusual Glycopeptides. J Proteome Res. 2016 09 02; 15(9):3358-76. Miyamoto S, Ruhaak LR, Stroble C, Salemi MR, Phinney B, Lebrilla CB, Leiserowitz GS. PMID: 27500424; PMCID: PMC5466807.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    17. Refusal of Recommended Chemotherapy for Ovarian Cancer: Risk Factors and Outcomes; a National Cancer Data Base Study. J Natl Compr Canc Netw. 2016 05; 14(5):539-50. Wallace SK, Lin JF, Cliby WA, Leiserowitz GS, Tergas AI, Bristow RE. PMID: 27160232.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    18. Protein-Specific Differential Glycosylation of Immunoglobulins in Serum of Ovarian Cancer Patients. J Proteome Res. 2016 Mar 04; 15(3):1002-10. Ruhaak LR, Kim K, Stroble C, Taylor SL, Hong Q, Miyamoto S, Lebrilla CB, Leiserowitz G. PMID: 26813784; PMCID: PMC5637400.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    19. Characteristics of Long-Term Survivors of Epithelial Ovarian Cancer. Obstet Gynecol. 2015 Sep; 126(3):491-497. Cress RD, Chen YS, Morris CR, Petersen M, Leiserowitz GS. PMID: 26244529; PMCID: PMC4545401.
      View in: PubMed   Mentions: 90     Fields:    Translation:Humans
    20. Preserving sexual function in women and girls with cancer: survivorship is about more than just surviving. Am J Obstet Gynecol. 2015 Aug; 213(2):119-20. Kennedy VA, Leiserowitz GS. PMID: 26216177.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    21. The impact of a vaginal brachytherapy boost to pelvic radiation in stage III endometrial cancer. J Contemp Brachytherapy. 2015 Apr; 7(2):122-7. Huddleston A, Zhen S, Qi L, Rash D, Leiserowitz G, Mayadev J. PMID: 26034492; PMCID: PMC4444456.
      View in: PubMed   Mentions: 7  
    22. Evaluation of glycomic profiling as a diagnostic biomarker for epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2014 Apr; 23(4):611-21. Kim K, Ruhaak LR, Nguyen UT, Taylor SL, Dimapasoc L, Williams C, Stroble C, Ozcan S, Miyamoto S, Lebrilla CB, Leiserowitz GS. PMID: 24557531; PMCID: PMC4230493.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    23. Accounting for undetected compounds in statistical analyses of mass spectrometry 'omic studies. Stat Appl Genet Mol Biol. 2013 Dec; 12(6):703-22. Taylor SL, Leiserowitz GS, Kim K. PMID: 24246290; PMCID: PMC3905689.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    24. Chip-based nLC-TOF-MS is a highly stable technology for large-scale high-throughput analyses. Anal Bioanal Chem. 2013 May; 405(14):4953-8. Ruhaak LR, Taylor SL, Miyamoto S, Kelly K, Leiserowitz GS, Gandara D, Lebrilla CB, Kim K. PMID: 23525540; PMCID: PMC3640767.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    25. Isomer-specific chromatographic profiling yields highly sensitive and specific potential N-glycan biomarkers for epithelial ovarian cancer. J Chromatogr A. 2013 Mar 01; 1279:58-67. Hua S, Williams CC, Dimapasoc LM, Ro GS, Ozcan S, Miyamoto S, Lebrilla CB, An HJ, Leiserowitz GS. PMID: 23380366; PMCID: PMC5628020.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    26. The glycolyzer: automated glycan annotation software for high performance mass spectrometry and its application to ovarian cancer glycan biomarker discovery. Proteomics. 2012 Aug; 12(15-16):2523-38. Kronewitter SR, De Leoz ML, Strum JS, An HJ, Dimapasoc LM, Guerrero A, Miyamoto S, Lebrilla CB, Leiserowitz GS. PMID: 22903841; PMCID: PMC3567444.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    27. Re: Surgical staging of early stage epithelial ovarian cancer. Gynecologic Oncology. 2011 Aug 1; 122(2):461-462. Cress CR, Leiserowitz LG. .
      View in: Publisher Site   Mentions:
    28. Venous thromboembolism in uterine cancer. Int J Gynecol Cancer. 2011 Jul; 21(5):870-6. Rodriguez AO, Gonik AM, Zhou H, Leiserowitz GS, White RH. PMID: 21666485.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    29. Surgical staging of early stage epithelial ovarian cancer: results from the CDC-NPCR ovarian patterns of care study. Gynecol Oncol. 2011 Apr; 121(1):94-9. Cress RD, Bauer K, O'Malley CD, Kahn AR, Schymura MJ, Wike JM, Stewart SL, Leiserowitz GS. PMID: 21256581.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    30. Human serum processing and analysis methods for rapid and reproducible N-glycan mass profiling. J Proteome Res. 2010 Oct 01; 9(10):4952-9. Kronewitter SR, de Leoz ML, Peacock KS, McBride KR, An HJ, Miyamoto S, Leiserowitz GS, Lebrilla CB. PMID: 20698584; PMCID: PMC2948646.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    31. Laparoscopic versus abdominal hysterectomy for endometrial cancer: comparison of patient outcomes. Int J Gynecol Cancer. 2009 Nov; 19(8):1370-6. Leiserowitz GS, Xing G, Parikh-Patel A, Cress R, Abidi A, Rodriguez AO, Dalrymple JL. PMID: 20009892; PMCID: PMC4357489.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    32. The development of retrosynthetic glycan libraries to profile and classify the human serum N-linked glycome. Proteomics. 2009 Jun; 9(11):2986-94. Kronewitter SR, An HJ, de Leoz ML, Lebrilla CB, Miyamoto S, Leiserowitz GS. PMID: 19452454; PMCID: PMC2758495.
      View in: PubMed   Mentions: 70     Fields:    Translation:Humans
    33. Detecting glycan cancer biomarkers in serum samples using MALDI FT-ICR mass spectrometry data. Bioinformatics. 2009 Jan 15; 25(2):251-7. Barkauskas DA, An HJ, Kronewitter SR, de Leoz ML, Chew HK, de Vere White RW, Leiserowitz GS, Miyamoto S, Lebrilla CB, Rocke DM. PMID: 19073586; PMCID: PMC2639011.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    34. Primary clear cell adenocarcinoma of the rectovaginal septum treated with concurrent chemoradiation therapy: a case report. Int J Gynecol Cancer. 2008 Sep-Oct; 18(5):1118-21. Guiou M, Hall WH, Konia T, Scudder S, Leiserowitz G, Ryu JK. PMID: 17986241.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    35. Factors associated with the suboptimal treatment of women less than 55 years of age with early-stage ovarian cancer. Gynecol Oncol. 2008 Jan; 108(1):95-9. Chan JK, Kapp DS, Shin JY, Osann K, Leiserowitz GS, Cress RD, O'Malley C. PMID: 17949796.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    36. Glycomics analysis of serum: a potential new biomarker for ovarian cancer? Int J Gynecol Cancer. 2008 May-Jun; 18(3):470-5. Leiserowitz GS, Lebrilla C, Miyamoto S, An HJ, Duong H, Kirmiz C, Li B, Liu H, Lam KS. PMID: 17655680; PMCID: PMC2581843.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    37. Influence of the gynecologic oncologist on the survival of ovarian cancer patients. Obstet Gynecol. 2007 Jun; 109(6):1342-50. Chan JK, Kapp DS, Shin JY, Husain A, Teng NN, Berek JS, Osann K, Leiserowitz GS, Cress RD, O'Malley C. PMID: 17540806.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    38. Ovarian cancer in younger vs older women: a population-based analysis. Br J Cancer. 2006 Nov 20; 95(10):1314-20. Chan JK, Urban R, Cheung MK, Osann K, Shin JY, Husain A, Teng NN, Kapp DS, Berek JS, Leiserowitz GS. PMID: 17088903; PMCID: PMC2360593.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    39. Managing ovarian masses during pregnancy. Obstet Gynecol Surv. 2006 Jul; 61(7):463-70. Leiserowitz GS. PMID: 16787549.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    40. Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer. J Proteome Res. 2006 Jul; 5(7):1626-35. An HJ, Miyamoto S, Lancaster KS, Kirmiz C, Li B, Lam KS, Leiserowitz GS, Lebrilla CB. PMID: 16823970.
      View in: PubMed   Mentions: 96     Fields:    Translation:HumansCells
    41. Long-term results of maximally aggressive trimodality therapy in a high-risk subset of early-stage cervical cancer patients. J Reprod Med. 2006 May; 51(5):383-8. Elliott KS, Borowsky ME, Malka ES, Scudder SA, Leiserowitz GS, Russell AH. PMID: 16779984.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    42. Adnexal masses in pregnancy: how often are they malignant? Gynecol Oncol. 2006 May; 101(2):315-21. Leiserowitz GS, Xing G, Cress R, Brahmbhatt B, Dalrymple JL, Smith LH. PMID: 16310839.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    43. Case report: Malignant peripheral nerve sheath tumor of the uterine cervix treated with radical vaginal trachelectomy. Gynecol Oncol. 2006 Jan; 100(1):201-4. Rodriguez AO, Truskinovsky AM, Kasrazadeh M, Leiserowitz GS. PMID: 16182351.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    44. Pregnancy-associated cervical cancer: obstetric outcomes. J Matern Fetal Neonatal Med. 2005 Apr; 17(4):269-76. Dalrymple JL, Gilbert WM, Leiserowitz GS, Cress R, Xing G, Danielsen B, Smith LH. PMID: 16147836.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    45. Chemoradiation for primary invasive squamous carcinoma of the vagina. Int J Gynecol Cancer. 2004 Jan-Feb; 14(1):110-7. Dalrymple JL, Russell AH, Lee SW, Scudder SA, Leiserowitz GS, Kinney WK, Smith LH. PMID: 14764038.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    46. Survival of Californian women with epithelial ovarian cancer, 1994-1996: a population-based study. Gynecol Oncol. 2003 Dec; 91(3):608-15. O'Malley CD, Cress RD, Campleman SL, Leiserowitz GS. PMID: 14675685.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    47. Endometriosis-related malignancies. Int J Gynecol Cancer. 2003 Jul-Aug; 13(4):466-71. Leiserowitz GS, Gumbs JL, Oi R, Dalrymple JL, Smith LH, Ryu J, Scudder S, Russell AH. PMID: 12911723.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    48. Patterns of chemotherapy use for women with ovarian cancer: a population-based study. J Clin Oncol. 2003 Apr 15; 21(8):1530-5. Cress RD, O'Malley CD, Leiserowitz GS, Campleman SL. PMID: 12697877.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    49. Obstetrical deliveries associated with maternal malignancy in California, 1992 through 1997. Am J Obstet Gynecol. 2001 Jun; 184(7):1504-12; discussion 1512-3. Smith LH, Dalrymple JL, Leiserowitz GS, Danielsen B, Gilbert WM. PMID: 11408874.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    50. Catamenial fevers associated with a uterine smooth muscle tumor of undetermined malignant potential. Obstet Gynecol. 1998 Oct; 92(4 Pt 2):671-2. Wong AW, Leiserowitz GS, McCausland VM, McCausland AM. PMID: 9764658.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    51. Prophylactic chemoradiation of inguinofemoral lymph nodes in patients with locally extensive vulvar cancer. Gynecol Oncol. 1997 Sep; 66(3):509-14. Leiserowitz GS, Russell AH, Kinney WK, Smith LH, Taylor MH, Scudder SA. PMID: 9299268.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    52. Detection of serologic neutralizing antibodies against HPV-11 in patients with condyloma acuminata and cervical dysplasia using an in vitro assay. Gynecol Oncol. 1997 Aug; 66(2):295-9. Leiserowitz GS, Hall KS, Foster CA, Hitchcock ME, Christensen ND, Heim K, Smith LH. PMID: 9264579.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    53. Monoclonal antibodies to HPV-6 L1 virus-like particles identify conformational and linear neutralizing epitopes on HPV-11 in addition to type-specific epitopes on HPV-6. Virology. 1996 Oct 15; 224(2):477-86. Christensen ND, Reed CA, Cladel NM, Hall K, Leiserowitz GS. PMID: 8874508.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansAnimalsCells
    54. Treatment of placental site trophoblastic tumor with hysterotomy and uterine reconstruction. Obstet Gynecol. 1996 Oct; 88(4 Pt 2):696-9. Leiserowitz GS, Webb MJ. PMID: 8841257.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    55. Titration of HPV-11 infectivity and antibody neutralization can be measured in vitro. J Invest Dermatol. 1995 Sep; 105(3):438-44. Smith LH, Foster C, Hitchcock ME, Leiserowitz GS, Hall K, Isseroff R, Christensen ND, Kreider JW. PMID: 7665926.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    56. The proto-oncogene c-fms is overexpressed in endometrial cancer. Gynecol Oncol. 1993 May; 49(2):190-6. Leiserowitz GS, Harris SA, Subramaniam M, Keeney GL, Podratz KC, Spelsberg TC. PMID: 8504987.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    57. Creatine kinase and its MB isoenzyme in the third trimester and the peripartum period. J Reprod Med. 1992 Nov; 37(11):910-6. Leiserowitz GS, Evans AT, Samuels SJ, Omand K, Kost GJ. PMID: 1460608.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    With one click, see people who:

    Mentor

    Offer Student Projects

    Run Clinical Trials

    See more options in the Advanced Search tab

    Gary's Networks
    Concepts (238)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (36)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UC Davis Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California